Inventor

IGAWA TOMOYUKI

JP114 patents

⚠️ This page may combine multiple inventors who share the name “IGAWA TOMOYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IGAWA TOMOYUKI

CHUGAI PHARMACEUTICAL CO LTD

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

Method of modifying isoelectric point of antibody via amino acid substitution in CDR

IL-8 antibodies

Anti-glypican 3 antibody

Method of modifying isoelectric point of antibody via amino acid substitution in CDR

Methods for producing polypeptides by regulating polypeptide association

Antigen-binding molecule containing modified Fc region

Methods of modifying antibodies for purification of bispecific antibodies

Methods of reducing IL-6 activity for disease treatment

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

Antibody constant region variant

Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance

Antibody constant region variant

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

FcgammaRIIB-specific Fc region variant

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Nucleic acids encoding IL-8 antibodies

Ion concentration-dependent binding molecule library

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Cytotoxicity-inducing theraputic agent

Methods of treatment that include the administration of bispecific antibodies

Multispecific antigen-binding molecules having blood coagulation factor VIII (FVIII) cofactor function-substituting activity and pharmaceutical formulations containing such a molecule as an active ingredient

Nucleic acids encoding anti-NR10 antibodies

Method of modifying isoelectric point of antibody via amino acid substitution in CDR

Method of modifying isoelectric point of antibody via amino acid substitution in CDR

Modified antibody constant region

Method for altering plasma retention and immunogenicity of antigen-binding molecule

Immunoactivating antigen-binding molecule

Fc region variant

Method for producing polypeptide hetero-oligomer

Method for producing polypeptide heteromultimer

Heterodimerized polypeptide

IGAWA TOMOYUKI

Method of modifying isoelectric point of antibody via amino acid substitution in CDR

Methods for producing polypeptides by regulating polypeptide association

Modified antibody constant region

Antibody constant region variant

Antibody molecules that bind to IL-6 receptor

Bispecific antibodies

Methods for controlling blood pharmacokinetics of antibodies

Methods of modifying antibodies for purification of bispecific antibodies

Method for altering plasma retention and immunogenicity of antigen-binding molecule

Stabilizer for protein preparation comprising meglumine and use thereof

Anti-glypican-3 antibody having improved kinetics in plasma

Stabilized antibody-containing liquid formulations

KURAMOCHI TAICHI

Antibody constant region variants with reduced Fcgammar binding

Anti-NR10 antibody and use thereof

Modified antibody constant regions

NEZU JUNICHI

Cytotoxicity-inducing therapeutic agent

MIMOTO FUTA

Heterodimerized polypeptide

MAEDA ATSUHIKO

Anti-AXL antibody